Across health care, clinicians are increasingly using patient-reported outcome measures (PROMs) to give a voice to patients and to help standardize the assessment of patients for comparison purposes. With this increasing use, the limitations of these PROMs should not be underestimated within the diverse population that we treat.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Beutel, M. E. et al. Sexual activity, sexual and partnership satisfaction in ageing men — results from a German representative community study. Andrologia 34, 22–28 (2002).
Rosen, R. C. et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49, 822–830 (1997).
Wei, J. T., Dunn, R. L., Litwin, M. S., Sandler, H. M. & Sanda, M. G. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56, 899–905 (2000).
Institute of Medicine (US) Committee on Lesbian, Gay, Bisexual, and Transgender Health Issues and Research Gaps and Opportunities. The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding (National Academies Press, 2011).
Meyer, I. H. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol. Bull. 129, 674–697 (2003).
Rosser, B. R. S. et al. Understanding prostate cancer in gay, bisexual, and other men who have sex with men and transgender women: a review of the literature. Curr. Sex. Health Rep. 11, 430–441 (2019).
Hoyt, M. A. et al. Gay men’s experiences with prostate cancer: implications for future research. J. Health Psychol. 25, 298–310 (2020).
Polter, E. J. et al. Creation and psychometric validation of the Sexual Minorities and Prostate Cancer Scale (SMACS) in sexual minority patients-the Restore-2 study. J. Sex. Med. 19, 529–540 (2022).
Kinnaird, W. et al. The management of sexual dysfunction resulting from radiotherapy and androgen deprivation therapy to treat prostate cancer: a comparison of uro-oncology practice according to disease stage. Int. J. Clin. Pract. 75, e13873 (2021).
Rosser, B. R. S. et al. Acceptability and feasibility of collecting sexual orientation and expanded gender identity data in urology and oncology clinics. LGBT Health 8, 420–426 (2021).
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
F.M., M.S. and A.S. have received an unrestricted education grant from Boston Scientific. T.Y. declares no competing interests.
Additional information
Related links
British Association for Sexual Health and HIV: https://www.bashhguidelines.org/current-guidelines/sexual-history-taking-sti-testing-and-specific-groups/sexual-history-taking-2019/
Rights and permissions
About this article
Cite this article
MacAskill, F., Sahai, A., Shabbir, M. et al. Is it time to rethink the current patient-reported outcome measures?. Nat Rev Urol 20, 1–2 (2023). https://doi.org/10.1038/s41585-022-00661-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-022-00661-7
